Gut-Lung Digital Programme

Respiratory continuity,with gut-health context.

A clinician-accountable pathway between clinic visits

Partner-clinic onboarding, clinician-guided support and digital follow-through for people living with COPD and other chronic respiratory conditions.

Clinic partnership conversations openClinician-accountableDigital programme launching
Clinic ↔ home continuityProgramme pathway
ContextFollow-throughReviewLearning

The participant journey

The programme starts before the device is complete.

Care continuity can begin through partner clinics while VAYU is developed and validated as a separate physical product.

  1. 01Partner clinicEligibility and context
  2. 02BaselineClinical starting point
  3. 03Individual planClinician-approved
  4. 04Digital follow-throughBetween visits
  5. 05Clinical reviewInterpret and adapt
  6. 06Longitudinal evidenceLearn over time

One programme, four accountable layers

Digital does not mean detached from care.

The programme connects a clinical starting point with a followable plan, real-world context and scheduled review.

  1. 01
    Clinical layer

    Care remains clinician-led.

    Partner clinics establish eligibility, clinical context, treatment boundaries and review points.

  2. 02
    Gut-health layer

    Protocols become followable.

    Nutrition, lifestyle and adherence support can be organised around a defined, clinician-approved plan.

  3. 03
    Digital layer

    Context continues between visits.

    Symptoms, medication context, routines and patient-reported outcomes can be followed over time.

  4. 04
    Evidence layer

    The programme learns carefully.

    Governed longitudinal evidence can refine the programme and, where separately consented, inform VAYU’s design.

The learning loop

Follow the response, not only the recommendation.

Select each stage to see how a governed programme can move from measurement to a clinician- or protocol-led action, then back to repeated observation.

Step 01

Sense

Capture a standardised physical or biological signal with enough context to know whether it is usable.

Programme focus

Begin with respiratory continuity. Validate every expansion.

Initial programme focus

COPD and chronic lung conditions

Support continuity around established respiratory care while studying the context needed for gut-lung research.

Future research collaboration

Lung oncology

Explore longitudinal context for earlier-signal, response and recurrence research without replacing oncology diagnosis, monitoring or treatment.

Separate future research pathway

Gut-brain and cognition

Investigate cognition and neurodegeneration-related biomarkers in purpose-built studies, not as a dementia treatment claim.

Clinical boundary

Support care. Do not impersonate it.

Clinicians remain responsible for diagnosis and treatment. The programme complements established respiratory care; it does not replace prescribed treatment, pulmonary rehabilitation, escalation or clinical review.

Clinician-approved plansClear escalation routesConsent-led evidence useNo autonomous prescribing

Build the first clinic-connected cohort with us.

VSNOVA is opening conversations with respiratory clinics, microbiome laboratories and research partners interested in a governed, measurable programme.

Discuss a partnership